Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Fatigue prevalence and associated factors in patients with multiple system atrophy.

Tytuł:
Fatigue prevalence and associated factors in patients with multiple system atrophy.
Autorzy:
Xu, Fang
Wang, Hui
Zhao, Quanzhen
Huang, Hongyan
Ning, Pingping
Shen, Qiuyan
Xie, Dan
Lu, Haitao
Xu, Yanming
Temat:
MULTIPLE system atrophy
RAPID eye movement sleep
LOGISTIC regression analysis
EPWORTH Sleepiness Scale
QUALITY of life
Źródło:
Acta Neurologica Scandinavica; Nov2021, Vol. 144 Issue 5, p553-558, 6p
Czasopismo naukowe
Objective: Fatigue was reported a determinant of poor quality of life in multiple system atrophy (MSA) patients. This study aimed to determine fatigue prevalence and associated demographic, motor, and non‐motor symptoms in MSA patients. Materials and methods: A total of 174 MSA patients met "Probable" diagnostic criteria were included in this cross‐sectional study. Fatigue Severity Scale (FSS) was used to measure fatigue prevalence. Unified MSA Rating Scale (UMSARS), Non‐Motor Symptoms Scale (NMSS), Hamilton Depression Rating Scale‐17 (HDRS‐17), Hamilton Anxiety Scale (HAMA), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ), and Mini‐Mental State Exam (MMSE) were used for comprehensive clinical assessments. Nonparametric Mann–Whitney or Pearson's chi‐square test was used to compare the patient score with or without fatigue (defined as a mean FSS score≥4). Binary logistic regression analysis was performed to determine features independently associated with the presence of fatigue. Results: Fifty (28.7%) patients enrolled reported fatigue. Results of multivariate analysis revealed that anxiety (OR = 3.01, 95% CI = 1.43–6.31), excessive daytime sleepiness (OR = 2.70, 95% CI = 1.23–5.90), and use of sleep medicine (OR = 3.58, 95% CI = 1.39–9.24) were significantly associated with fatigue in MSA patients. Conclusions: Fatigue is common in our MSA patients. Anxiety, excessive daytime sleepiness, and current sleep medicine use may be associated with an increased risk of fatigue. However, the severity of motor symptoms may not be associated with fatigue. Our findings highlight the need to identify, investigate, and treat fatigue in MSA. [ABSTRACT FROM AUTHOR]
Copyright of Acta Neurologica Scandinavica is the property of Hindawi Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies